CRISPR Gene Editing in Stem Cells

23 128

adult stem cell properties derived from pluripotent stem cells. Stem Cell
Reports 2 , 838–852.
Fredriksson, N.J., Ny, L., Nilsson, J.A., and Larsson, E. (2014). Systematic
analysis of noncoding somatic mutations and gene expression alterations
across 14 tumor types. Nat. Genet. 46, 1258–1263.
Frock, R.L., Hu, J., Meyers, R.M., Ho, Y.J., and Kii, E. (2015). Genome-wide
detection of DNA double-stranded breaks induced by engineered nucleases.
Nat. Biotechnol. 33, 179–186.
Fu, Y., Foden, J.A., Khayter, C., Maeder, M.L., Reyon, D., Joung, J.K., and
Sander, J.D. (2013). High-frequency off-target mutagenesis induced by
CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31, 822–826.
Fu, Y., Sander, J.D., Reyon, D., Cascio, V.M., and Joung, J.K. (2014).
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.
Nat. Biotechnol. 32, 279–284.
Fusaki, N., Ban, H., Nishiyama, A., Saeki, K., and Hasegawa, M. (2009). Effi-
cient induction of transgene-free human pluripotent stem cells using a vector
based on Sendai virus, an RNA virus that does not integrate into the host
genome. Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. 85, 348–362.
Gabriel, R., Lombardo, A., Arens, A., Miller, J.C., Genovese, P., Kaeppel, C.,
Nowrouzi, A., Bartholomae, C.C., Wang, J., Friedman, G., et al. (2011). An
unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Bio-
technol. 29, 816–823.
Gibson, G. (2011). Rare and common variants: twenty arguments. Nat. Rev.
Genet. 13, 135–145.
Gilbert, L.A., Horlbeck, M.A., Adamson, B., Villalta, J.E., Chen, Y., Whitehead,
E.H., Guimaraes, C., Panning, B., Ploegh, H.L., Bassik, M.C., et al. (2014).
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.
Cell 159, 647–661.
Gonza´ lez, F., Zhu, Z., Shi, Z.D., Lelli, K., Verma, N., Li, Q.V., and Huangfu, D.
(2014). An iCRISPR platform for rapid, multiplexable, and inducible genome
editing in human pluripotent stem cells. Cell Stem Cell 15, 215–226.
Gratz, S.J., Cummings, A.M., Nguyen, J.N., Hamm, D.C., Donohue, L.K., Har-
rison, M.M., Wildonger, J., and O’Connor-Giles, K.M. (2013). Genome engi-
neering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics
194, 1029–1035.
Guenther, M.G., Frampton, G.M., Soldner, F., Hockemeyer, D., Mitalipova, M.,
Jaenisch, R., and Young, R.A. (2010). Chromatin structure and gene expres-
sion programs of human embryonic and induced pluripotent stem cells. Cell
Stem Cell 7 , 249–257.
Guo, Y., Xu, Q., Canzio, D., Shou, J., Li, J., Gorkin, D.U., Jung, I., Wu, H., Zhai,
Y., Tang, Y., et al. (2015). CRISPR Inversion of CTCF Sites Alters Genome
Topology and Enhancer/Promoter Function. Cell 162, 900–910.
Gurdon, J.B. (1962). The developmental capacity of nuclei taken from in-
testinal epithelium cells of feeding tadpoles. J. Embryol. Exp. Morphol. 10,
622–640.
Gurdon, J. (1963). Nuclear transplantation in Amphibia and the importance of
stable nuclear changes in cellular differentiation. Q. Rev. Biol. 38, 54–78.
Hart, T., Chandrashekhar, M., Aregger, M., Steinhart, Z., Brown, K.R., Ma-
cLeod, G., Mis, M., Zimmermann, M., Fradet-Turcotte, A., Sun, S., et al.
(2015). High-Resolution CRISPR Screens Reveal Fitness Genes and Geno-
type-Specific Cancer Liabilities. Cell 163, 1515–1526.
Hochedlinger, K., and Jaenisch, R. (2002). Monoclonal mice generated by nu-
clear transfer from mature B and T donor cells. Nature 415, 1035–1038.
Hockemeyer, D., and Jaenisch, R. (2010). Gene targeting in human pluripotent
cells. Cold Spring Harb. Symp. Quant. Biol. 75, 201–209.
Hockemeyer, D., Soldner, F., Beard, C., Gao, Q., Mitalipova, M., DeKelver,
R.C., Katibah, G.E., Amora, R., Boydston, E.A., Zeitler, B., et al. (2009). Effi-
cient targeting of expressed and silent genes in human ESCs and iPSCs using
zinc-finger nucleases. Nat. Biotechnol. 27, 851–857.
Hockemeyer, D., Wang, H., Kiani, S., Lai, C.S., Gao, Q., Cassady, J.P., Cost,
G.J., Zhang, L., Santiago, Y., Miller, J.C., et al. (2011). Genetic engineering of
human pluripotent cells using TALE nucleases. Nat. Biotechnol. 29, 731–734.
Horn, S., Figl, A., Rachakonda, P.S., Fischer, C., Sucker, A., Gast, A., Kadel,
S., Moll, I., Nagore, E., Hemminki, K., et al. (2013). TERT promoter mutations
in familial and sporadic melanoma. Science 339, 959–961.
Hou, Z., Zhang, Y., Propson, N.E., Howden, S.E., Chu, L.F., Sontheimer, E.J.,
and Thomson, J.A. (2013). Efficient genome engineering in human pluripotent
stem cells using Cas9 from Neisseria meningitidis. Proc. Natl. Acad. Sci. USA
110, 15644–15649.
Howden, S.E., Gore, A., Li, Z., Fung, H.L., Nisler, B.S., Nie, J., Chen, G., McIn-
tosh, B.E., Gulbranson, D.R., Diol, N.R., et al. (2011). Genetic correction and
analysis of induced pluripotent stem cells from a patient with gyrate atrophy.
Proc. Natl. Acad. Sci. USA 108, 6537–6542.
Howden, S.E., Maufort, J.P., Duffin, B.M., Elefanty, A.G., Stanley, E.G., and
Thomson, J.A. (2015). Simultaneous Reprogramming and Gene Correction
of Patient Fibroblasts. Stem Cell Reports 5, 1109–1118.
Hrvatin, S., O’Donnell, C.W., Deng, F., Millman, J.R., Pagliuca, F.W., DiIorio,
P., Rezania, A., Gifford, D.K., and Melton, D.A. (2014). Differentiated human
stem cells resemble fetal, not adult, b cells. Proc. Natl. Acad. Sci. USA 111,
3038–3043.
Hsu, P.D., Lander, E.S., and Zhang, F. (2014). Development and applications
of CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278.
Huang, F.W., Hodis, E., Xu, M.J., Kryukov, G.V., Chin, L., and Garraway, L.A.
(2013). Highly recurrent TERT promoter mutations in human melanoma. Sci-
ence 339, 957–959.
Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V.,
Li, Y., Fine, E.J., Wu, X., Shalem, O., et al. (2013). DNA targeting specificity of
RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827–832.
Hwang, W.Y., Fu, Y., Reyon, D., Maeder, M.L., Kaini, P., Sander, J.D., Joung,
J.K., Peterson, R.T., and Yeh, J.R. (2013a). Heritable and precise zebrafish
genome editing using a CRISPR-Cas system. PLoS ONE 8, e68708.
Hwang, W.Y., Fu, Y., Reyon, D., Maeder, M.L., Tsai, S.Q., Sander, J.D., Peter-
son, R.T., Yeh, J.R., and Joung, J.K. (2013b). Efficient genome editing in zebra-
fish using a CRISPR-Cas system. Nat. Biotechnol. 31, 227–229.
Irion, S., Luche, H., Gadue, P., Fehling, H.J., Kennedy, M., and Keller, G.
(2007). Identification and targeting of the ROSA26 locus in human embryonic
stem cells. Nat. Biotechnol. 25, 1477–1482.
Jiang, J., Jing, Y., Cost, G.J., Chiang, J.C., Kolpa, H.J., Cotton, A.M., Carone,
D.M., Carone, B.R., Shivak, D.A., Guschin, D.Y., et al. (2013). Translating
dosage compensation to trisomy 21. Nature 500, 296–300.
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., and Charpentier,
E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive
bacterial immunity. Science 337, 816–821.
Johnson, J.Z., and Hockemeyer, D. (2015). Human stem cell-based disease
modeling: prospects and challenges. Curr. Opin. Cell Biol. 37, 84–90.
Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., and Woltjen, K.
(2009). Virus-free induction of pluripotency and subsequent excision of re-
programming factors. Nature 458, 771–775.
Kang, L., Wang, J., Zhang, Y., Kou, Z., and Gao, S. (2009). iPS cells can sup-
port full-term development of tetraploid blastocyst-complemented embryos.
Cell Stem Cell 5, 135–138.
Kang, X., He, W., Huang, Y., Yu, Q., Chen, Y., Gao, X., Sun, X., and Fan, Y.
(2016). Introducing precise genetic modifications into human 3PN embryos
by CRISPR/Cas-mediated genome editing. J. Assist. Reprod. Genet., in press
April 6, 2016.
Killela, P.J., Reitman, Z.J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L.A.,
Jr., Friedman, A.H., Friedman, H., Gallia, G.L., Giovanella, B.C., et al. (2013).
TERT promoter mutations occur frequently in gliomas and a subset of tumors
derived from cells with low rates of self-renewal. Proc. Natl. Acad. Sci. USA
110, 6021–6026.
Kim, D., Kim, C.H., Moon, J.I., Chung, Y.G., Chang, M.Y., Han, B.S., Ko, S.,
Yang, E., Cha, K.Y., Lanza, R., and Kim, K.S. (2009). Generation of human
induced pluripotent stem cells by direct delivery of reprogramming proteins.
Cell Stem Cell 4, 472–476.
Cell Stem Cell 18, May 5, 2016 583
Cell Stem Cell
Review